Answers are grounded in this paper and cite their sources.
Perfluoroalkyl substances (PFAS) are a group of persistent environmental pollutants that pose significant risks to the human immune system and increase the likelihood of various immune-related diseases. Vitamin C is a common antioxidant that is widely used in clinical practice to manage immune-related disorders. Vitamin C shows potential in counteracting PFAS-induced immunotoxicity via multiple mechanisms, however, the dose-response relationships and the need for human clinical trials is still largely unknown. This brief overview highlights that vitamin C may mitigate immune system damage caused by PFAS, enhance immune cell function, and reduce the risk of chronic inflammation and immunosuppression through its antioxidant, anti-inflammatory, and immunomodulatory properties. Currently, experimental and clinical evidence remains limited. Future research should further investigate the clinical potential of vitamin C in treating immune disorders associated with PFAS exposure, clarify the dose-response relationships and contribute to the development of strategies to protect public health and the environment.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: